Found: 251
Select item for more details and to access through your institution.
Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 6, p. 1069, doi. 10.1002/ehf2.12355
- By:
- Publication type:
- Article
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1199, doi. 10.1111/dom.13642
- By:
- Publication type:
- Article
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 17, p. 2009, doi. 10.1001/jama.298.17.2009
- By:
- Publication type:
- Article
32-OR: The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-32-OR
- By:
- Publication type:
- Article
Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 1, p. 13, doi. 10.1111/1755-5922.12053
- By:
- Publication type:
- Article
Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function.
- Published in:
- Cardiology, 2015, v. 130, n. 1, p. 17, doi. 10.1159/000368220
- By:
- Publication type:
- Article
Neurohormonal Activation in Acute Heart Failure: Results from VERITAS.
- Published in:
- Cardiology, 2011, v. 119, n. 2, p. 96, doi. 10.1159/000330409
- By:
- Publication type:
- Article
Ghidul ESC de diagnostic şi tratament al insuficienţei cardiace acute şi cronice 2012.
- Published in:
- Romanian Journal of Cardiology, 2013, v. 23, n. 3, p. 245
- By:
- Publication type:
- Article
Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1727, doi. 10.1002/ejhf.3294
- By:
- Publication type:
- Article
Cardiovascular‐kidney‐metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1762, doi. 10.1002/ejhf.3304
- By:
- Publication type:
- Article
Use of medical therapy and risk of clinical events according to frailty in heart failure patients – A real‐life cohort study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1717, doi. 10.1002/ejhf.3249
- By:
- Publication type:
- Article
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1539, doi. 10.1002/ejhf.3269
- By:
- Publication type:
- Article
Dapagliflozin and quality of life measured using the EuroQol 5‐dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1524, doi. 10.1002/ejhf.3263
- By:
- Publication type:
- Article
Measuring congestion with a non‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1383, doi. 10.1002/ejhf.3290
- By:
- Publication type:
- Article
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1125, doi. 10.1002/ejhf.3223
- By:
- Publication type:
- Article
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON‐HF study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 871, doi. 10.1002/ejhf.3167
- By:
- Publication type:
- Article
Cost‐effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA‐HF and DELIVER data.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 3, p. 664, doi. 10.1002/ejhf.3197
- By:
- Publication type:
- Article
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 245, doi. 10.1002/ejhf.3114
- By:
- Publication type:
- Article
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 107, doi. 10.1002/ejhf.3085
- By:
- Publication type:
- Article
Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231).
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 142, doi. 10.1002/ejhf.3077
- By:
- Publication type:
- Article
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2202, doi. 10.1002/ejhf.3044
- By:
- Publication type:
- Article
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE‐HF model.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 1962, doi. 10.1002/ejhf.3028
- By:
- Publication type:
- Article
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 2078, doi. 10.1002/ejhf.3000
- By:
- Publication type:
- Article
Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1831, doi. 10.1002/ejhf.2944
- By:
- Publication type:
- Article
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1663, doi. 10.1002/ejhf.3001
- By:
- Publication type:
- Article
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1606, doi. 10.1002/ejhf.2962
- By:
- Publication type:
- Article
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1213, doi. 10.1002/ejhf.2965
- By:
- Publication type:
- Article
Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1396, doi. 10.1002/ejhf.2957
- By:
- Publication type:
- Article
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1444, doi. 10.1002/ejhf.2952
- By:
- Publication type:
- Article
The cost‐effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health‐economic analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1386, doi. 10.1002/ejhf.2940
- By:
- Publication type:
- Article
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1364, doi. 10.1002/ejhf.2912
- By:
- Publication type:
- Article
Incremental prognostic value of biomarkers in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1406, doi. 10.1002/ejhf.2887
- By:
- Publication type:
- Article
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy‐associated genes: A subgroup analysis of the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1256, doi. 10.1002/ejhf.2886
- By:
- Publication type:
- Article
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 1170, doi. 10.1002/ejhf.2915
- By:
- Publication type:
- Article
Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant‐level pooled analysis from the DAPA‐HF and DELIVER trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 981, doi. 10.1002/ejhf.2909
- By:
- Publication type:
- Article
Potential global impact of sodium–glucose cotransporter‐2 inhibitors in heart failure.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 999, doi. 10.1002/ejhf.2864
- By:
- Publication type:
- Article
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM‐HF and ATMOSPHERE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 5, p. 687, doi. 10.1002/ejhf.2856
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 488, doi. 10.1002/ejhf.2818
- By:
- Publication type:
- Article
Cost‐effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 2, p. 238, doi. 10.1002/ejhf.2777
- By:
- Publication type:
- Article
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 2, p. 248, doi. 10.1002/ejhf.2763
- By:
- Publication type:
- Article
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 87, doi. 10.1002/ejhf.2703
- By:
- Publication type:
- Article
Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 54, doi. 10.1002/ejhf.2699
- By:
- Publication type:
- Article
Health‐related quality of life outcomes in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2264, doi. 10.1002/ejhf.2738
- By:
- Publication type:
- Article
Reply to 'The 50 shades of bilirubin'. Letter regarding the article 'Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2206, doi. 10.1002/ejhf.2683
- By:
- Publication type:
- Article
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1918, doi. 10.1002/ejhf.2663
- By:
- Publication type:
- Article
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1892, doi. 10.1002/ejhf.2652
- By:
- Publication type:
- Article
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article